SSi Mantra approved in Colombia, Oman, Sri Lanka, Kenya; total approvals now 11 countries

SS Innovations International, Inc.

Regulatory approvals from INVIMA (Colombia, Nov 2025), DGPA&DC (Oman, Nov 2025), NMRA (Sri Lanka, Jan 2026), and PPB (Kenya, Jan 2026).
Cumulative installed base of SSi Mantra reached 168 systems across 10 countries as of Dec 31, 2025.
Cumulative surgeries total 7,885 including 390 cardiac and 121 pediatric; over 150 telesurgeries performed.
Company anticipates FDA 510(k) decision by mid-2026 and CE marking in 2026 for SSi Mantra.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.